Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Dietry supplements group OptiBiotix Health said subsidiary ProBiotix had signed a new global manufacturing and supply agreement with Sacco.
The pact modified and extended an existing relationship between the companies through to the end of 2023.
It changed an original profit-sharing agreement to a manufacture and supply agreement, with pricing discounts for increasing sales volumes.
'This allows the company to benefit from a reduced price of goods as sales volumes grow and provide more evenly distributed income throughout the year,' OptiBiotix said.
At 9:12am: (LON:OPTI) Optibiotix Health Plc share price was +1p at 43.5p